Atlas Trials

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Clinical trial NCT01523015 · UNKNOWN

Trial details

NCT number
NCT01523015
Sponsor
Medical University of Lublin
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Adenocarcinoma of the Gastroesophageal Junction
Start date
2012-01-01
Primary completion
2015-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.